Rituximab may not lead to increased infection rates in transplant recipients.
M
M
Drage
V
V
Hadjianastassiou
A
A
Dorling
N
N
Mamode
D058846:Antibodies, Monoclonal, Murine-Derived / Q000009:adverse effects*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D007239:Infections / Q000209:etiology*; D016030:Kidney Transplantation / Q000009:adverse effects*; D000069283:Rituximab
D058846:Antibodies, Monoclonal, Murine-Derived; D007166:Immunosuppressive Agents; D000069283:Rituximab